Patents by Inventor Mark Milton-Edwards

Mark Milton-Edwards has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160293054
    Abstract: A medicament-free device (e.g., a smartphone device) for simulating a medicament dispenser may include a sensing device and a processor. The sensing device may sense a user action performed upon the medicament-free device and may output sense data. The processor may receive the sense data, compare the sense data with predefined data, and provide feedback based on how the sense data compares to the predefined data. The predefined data may be indicative of a model user action associated with the medicament dispenser.
    Type: Application
    Filed: November 11, 2015
    Publication date: October 6, 2016
    Applicant: Teva UK Limited
    Inventor: Mark Milton-Edwards
  • Publication number: 20160158469
    Abstract: An inhalation monitoring system includes an inhaler having a medicament delivery apparatus configured to deliver medicament to a user during an inhalation of the user; inhalation monitoring apparatus, configured to, during the inhalation, gather data for determining a measure of the user's lung function and/or lung health; and a processor configured to receive the data from the inhalation monitoring apparatus and, using the data, determine a measure of the user's lung function and/or lung health.
    Type: Application
    Filed: July 17, 2015
    Publication date: June 9, 2016
    Applicants: MicroDose Therapeutx, Inc., Teva UK Limited
    Inventors: Mark Milton-Edwards, Henry Chrystyn, Mark Steven Morrison, Douglas E. Weitzel
  • Patent number: D782650
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: March 28, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Patent number: D782651
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: March 28, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Patent number: D782652
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: March 28, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Patent number: D783156
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Patent number: D783157
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Patent number: D783158
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 4, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann
  • Patent number: D783805
    Type: Grant
    Filed: April 7, 2014
    Date of Patent: April 11, 2017
    Assignee: TEVA Pharmaceutical Industries Limited
    Inventors: Mark Milton-Edwards, Michiel Ullmann